46 related articles for article (PubMed ID: 26279457)
1. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
3. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
5. New and Old Key Players in Liver Cancer.
Cuesta ÁM; Palao N; Bragado P; Gutierrez-Uzquiza A; Herrera B; Sánchez A; Porras A
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138981
[TBL] [Abstract][Full Text] [Related]
6. A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.
Hammam O; Mahmoud O; Zahran M; Sayed A; Salama R; Hosny K; Farghly A
Gastrointest Cancer Res; 2013 Jul; 6(4):107-14. PubMed ID: 24147158
[TBL] [Abstract][Full Text] [Related]
7. Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content.
Akl M; Hindawi AE; Mosaad M; Montasser A; Ray AE; Khalil H; Anas A; Atta R; Paradis V; Hadi AA; Hammam O
Open Access Maced J Med Sci; 2016 Dec; 4(4):578-584. PubMed ID: 28028394
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of
Ogawa M; Moriyama M; Nakamura H; Shibata T; Kuroda K; Sugitani M
J Clin Biochem Nutr; 2024 Mar; 74(2):169-178. PubMed ID: 38510682
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated epidermal growth factor and tumor growth factor-beta receptor signaling through
Hassan S; Zil-E-Rubab ; Shah H; Shawana S
Pak J Med Sci; 2020; 36(4):782-787. PubMed ID: 32494274
[TBL] [Abstract][Full Text] [Related]
10. The expression of VEGF and cyclin D1/EGFR in common primary liver carcinomas in Egypt: an immunohistochemical study.
Sweed D; Gammal SSE; Kilany S; Abdelsattar S; Elhamed SMA
Ecancermedicalscience; 2023; 17():1641. PubMed ID: 38414954
[TBL] [Abstract][Full Text] [Related]
11. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
Front Immunol; 2022; 13():890150. PubMed ID: 35686121
[TBL] [Abstract][Full Text] [Related]
12. Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway.
Zhang Y; Zhang Y; Shi XJ; Li JX; Wang LH; Xie CE; Wang YL
Front Oncol; 2022; 12():836333. PubMed ID: 35252007
[TBL] [Abstract][Full Text] [Related]
13. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.
Zhang X; Li X; Fu X; Yu M; Qin G; Chen G; Huang C
Front Oncol; 2021; 11():643362. PubMed ID: 34322376
[TBL] [Abstract][Full Text] [Related]
15. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.
Sepulveda-Crespo D; Resino S; Martinez I
Drugs; 2021 Mar; 81(4):419-443. PubMed ID: 33400242
[TBL] [Abstract][Full Text] [Related]
16. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
[TBL] [Abstract][Full Text] [Related]
17. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.
Lai Q; Vitale A; Manzia TM; Foschi FG; Levi Sandri GB; Gambato M; Melandro F; Russo FP; Miele L; Viganò L; Burra P; Giannini EG;
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31618961
[TBL] [Abstract][Full Text] [Related]
18. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.
Virzì A; Roca Suarez AA; Baumert TF; Lupberger J
Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501266
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.
Borges MB; Marchevsky RS; Mendes YS; Mendes LG; Duarte AC; Cruz M; de Filippis AMB; Vasconcelos PFC; Freire M; Homma A; Mossman S; Lepine E; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
PLoS One; 2018; 13(4):e0196311. PubMed ID: 29694440
[TBL] [Abstract][Full Text] [Related]
20. EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C.
Asnavandi M; Zargar M; Vaziri F; Jamnani FR; Gharibzadeh S; Fateh A; Siadat SD
Genes Immun; 2017 Sep; 18(3):144-151. PubMed ID: 28703131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
